Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by mdjbrownon Dec 22, 2023 8:51am
96 Views
Post# 35797326

RE:Very bullish...good times ahead! Golden parachutes issued!!!

RE:Very bullish...good times ahead! Golden parachutes issued!!!Not exactly the stocking stuffer I was anticipating s1i, and time will tell, but the optics of a board resignation while the remaining management group issues themselves a huge pat on the back right before Christmas are not great, and ring of arrogance regarding the timing considering so many shareholders are well under water.

If the incentive awards were all .065 stock options, I could live with that, but continued RSU's just dilute the shareholders out at no benefit at all to anyone but the holder of those RSUs.

2024 is a pivotal year for Medipharm, as the mystery international partners needs to be made public.

All the very best to everyone this Holiday Season, and heres to an amazing 2024! 




<< Previous
Bullboard Posts
Next >>